Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody

Suppression of T cell response is the key to enhance graft survival and control autoimmune diseases. A mitogenic anti-CD3 monoclonal antibody (mAb), OKT3, has been used for decades to control acute rejection in organ transplantation. Although effective, the clinical use was limited by its side effec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2006-06, Vol.6 (6), p.880-891
Hauptverfasser: Li, Jian, Davis, Janet, Bracht, Michelle, Carton, Jill, Armstrong, Jennifer, Gao, Wei, Scallon, Bernie, Fung, Ramie, Emmell, Eva, Zimmerman, Mark, Griswold, Don E., Li, Li
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!